Co-Author
This page shows the publications co-authored by Peter Caravan and Kenneth Tanabe.
Connection Strength
3.103
-
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver. Cell Mol Gastroenterol Hepatol. 2022 Jan 28.
Score: 0.246
-
Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. Sci Rep. 2021 Sep 07; 11(1):18167.
Score: 0.239
-
Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. Sci Rep. 2021 03 17; 11(1):6105.
Score: 0.232
-
Collagen-targeted molecular imaging in diffuse liver diseases. Abdom Radiol (NY). 2020 11; 45(11):3545-3556.
Score: 0.222
-
Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis. Radiology. 2020 07; 296(1):67-75.
Score: 0.218
-
Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation. Invest Radiol. 2020 04; 55(4):209-216.
Score: 0.217
-
CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology. 2018 05; 287(2):581-589.
Score: 0.184
-
Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight. 2017 Jun 02; 2(11).
Score: 0.178
-
Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model. Hepatology. 2017 03; 65(3):1015-1025.
Score: 0.173
-
T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg. 2016 Apr; 6(2):103-14.
Score: 0.164
-
3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol. 2015 Sep; 63(3):689-96.
Score: 0.155
-
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology. 2014 Apr; 59(4):1577-90.
Score: 0.142
-
Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol. 2013 Nov; 59(5):992-8.
Score: 0.136
-
Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol. 2012 Sep; 57(3):549-55.
Score: 0.126
-
Positron Emission Tomography/Magnetic Resonance Imaging Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis. Ann Surg. 2022 Feb 17.
Score: 0.062
-
Molecular Magnetic Resonance Imaging of Liver Fibrosis and Fibrogenesis Is Not Altered by Inflammation. Invest Radiol. 2021 04 01; 56(4):244-251.
Score: 0.058
-
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Clin Cancer Res. 2020 09 15; 26(18):5007-5018.
Score: 0.055
-
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Invest Radiol. 2019 11; 54(11):697-703.
Score: 0.053
-
Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex. J Am Chem Soc. 2019 04 10; 141(14):5916-5925.
Score: 0.050
-
The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction. FASEB J. 2019 06; 33(6):7103-7112.
Score: 0.050
-
Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation. J Med Chem. 2018 10 11; 61(19):8811-8824.
Score: 0.049
-
Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Dis Model Mech. 2018 07 30; 11(7).
Score: 0.048
-
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist. Hepatol Commun. 2018 Jul; 2(7):821-835.
Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.